Palbospain: observational analysis of first-line therapy with palbociclib in patients with hr+/her2-metastatic breast cancer (mbc) in real-life conditions

CANCER RESEARCH(2023)

引用 0|浏览17
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要